Serena Massari

Dr. Serena Massari

Via del Liceo 1
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Serena MassariSerena Massari
Serena Massari
DDDirk Daelemans
Dirk Daelemans
MBMaria Letizia Barreca
Maria Letizia Barreca
AKAnna Knezevich
Anna Knezevich
SSStefano Sabatini
Stefano Sabatini
Oriana TabarriniOriana Tabarrini
Oriana Tabarrini

20 April 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Serena MassariSerena Massari
Serena Massari
Giulio NannettiGiulio Nannetti
Giulio Nannetti
JDJenny Desantis
Jenny Desantis
GMGiulia Muratore
Giulia Muratore
SSStefano Sabatini
Stefano Sabatini
Oriana TabarriniOriana Tabarrini
Oriana Tabarrini

20 August 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
Marco GargaroMarco Gargaro
Marco Gargaro
CVCarmine Vacca
Carmine Vacca
Serena MassariSerena Massari
Serena Massari
GSGiulia Scalisi
Giulia Scalisi
GMGiorgia Manni
Giorgia Manni
UGUrsula Grohmann
Ursula Grohmann
Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the first step in the kynurenine pathway of tryptophan (Trp) degradation that produces several biologically active Trp metabolites. L-kynurenine (Kyn), the first byproduct by IDO1, promotes immunoregulatory effects via activation of the Aryl hydrocarbon Receptor (AhR) in dendritic cells (DCs) and T lymphocytes. We here identified the nuclear coactivator 7 (NCOA7) as a molecular target of 3-hydroxyanthranilic acid (3-HAA), a Trp metabolite produced downstream of Kyn along the kynurenine pathway. In cells overexpressing NCOA7 and AhR, the presence of 3-HAA increased the association of the two molecules and enhanced Kyn-driven, AhR-dependent gene transcription. Physiologically, conventional (cDCs) but not plasmacytoid DCs or other immune cells expressed high levels of NCOA7. In cocultures of CD4+ T cells with cDCs, the co-addition of Kyn and 3-HAA significantly increased the induction of Foxp3+ regulatory T cells and the production of immunosuppressive transforming growth factor β in an NCOA7-dependent fashion. Thus, the co-presence of NCOA7 and the Trp metabolite 3-HAA can selectively enhance the activation of ubiquitary AhR in cDCs and consequent immunoregulatory effects. Because NCOA7 is often overexpressed and/or mutated in tumor microenvironments, our current data may provide evidence for a new immune check-point mechanism based on Trp metabolism and AhR.


3 May 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
MPMaria Chiara Pismataro
Maria Chiara Pismataro
AAAndrea Astolfi
Andrea Astolfi
MBMaria Letizia Barreca
Maria Letizia Barreca
MPMartina Pacetti
Martina Pacetti
SSSilvia Schenone
Silvia Schenone
Serena MassariSerena Massari
Serena Massari
Synthetic lethality (SL) is an innovative strategy in targeted anticancer therapy that exploits tumor genetic vulnerabilities. This topic has come to the forefront in recent years, as witnessed by the increased number of publications since 2007. The first proof of concept for the effectiveness of SL was provided by the approval of poly(ADP-ribose)polymerase inhibitors, which exploit a SL interaction in BRCA-deficient cells, although their use is limited by resistance. Searching for additional SL interactions involving BRCA mutations, the DNA polymerase theta (POLθ) emerged as an exciting target. This review summarizes, for the first time, the POLθ polymerase and helicase inhibitors reported to date. Compounds are described focusing on chemical structure and biological activity. With the aim to enable further drug discovery efforts in interrogating POLθ as a target, we propose a plausible pharmacophore model for POLθ-pol inhibitors and provide a structural analysis of the known POLθ ligand binding sites.

23 April 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Giuseppe ManfroniGiuseppe Manfroni
Giuseppe Manfroni
JPJan Paeshuyse
Jan Paeshuyse
Serena MassariSerena Massari
Serena Massari
SZSamantha Zanoli
Samantha Zanoli
BGBarbara Gatto
Barbara Gatto
JNJohan Hendrik Neyts
Johan Hendrik Neyts